Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03681249Phase 1Completed
Phase 1, randomised, double-blind trial in diabetic kidney disease (DKD) comparing ShenqiDihuang Decoction with Placebo (2 arms). Primary endpoint: 24-Hour Urine Total Protein at 24 weeks. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03681249.